Rankings
▼
Calendar
FATE Q1 2022 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FATE
Fate Therapeutics, Inc.
$158M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$18M
+65.3% YoY
Gross Profit
-$54M
-291.8% margin
Operating Income
-$74M
-404.4% margin
Net Income
-$66M
-356.7% margin
EPS (Diluted)
$-0.59
QoQ Revenue Growth
+7.9%
Cash Flow
Operating Cash Flow
-$65M
Free Cash Flow
-$75M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$858M
Total Liabilities
$225M
Stockholders' Equity
$633M
Cash & Equivalents
$65M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$18M
$11M
+65.3%
Gross Profit
-$54M
-$34M
-59.4%
Operating Income
-$74M
-$46M
-61.1%
Net Income
-$66M
-$45M
-45.7%
Revenue Segments
Upfront Fee And Equity Premium
$6M
100%
← FY 2022
All Quarters
Q2 2022 →